Upregulation of Monocyte/Macrophage HGFIN (Gpnmb/Osteoactivin) Expression in End-Stage Renal Disease
Open Access
- 1 January 2010
- journal article
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 5 (1), 56-61
- https://doi.org/10.2215/cjn.03390509
Abstract
Background and objectives: Hematopoietic growth factor–inducible neurokinin 1 (HGFIN), also known as Gpnmb and osteoactivin, is a transmembrane glycoprotein that is expressed in numerous cells, including osteoclasts, macrophages, and dendritic cells. It serves as an osteoblast differentiation factor, participates in bone mineralization, and functions as a negative regulator of inflammation in macrophages. Although measurable at low levels in monocytes, monocyte-to-macrophage transformation causes substantial increase in HGFIN expression. HGFIN is involved in systemic inflammation, bone demineralization, and soft tissue vascular calcification. Design, setting, participants, & measurements: We explored HGFIN expression in monocytes and monocyte-derived macrophages in 21 stable hemodialysis patients and 22 control subjects. Results: Dialysis patients exhibited marked upregulation of colony-stimulating factor and IL-6 and significant downregulation of IL-10 in intact monocytes and transformed macrophages. HGFIN expression in intact monocytes was negligible in control subjects but conspicuously elevated (8.6-fold) in dialysis patients. As expected, in vitro monocyte-to-macrophage transformation resulted in marked upregulation of HGFIN in cells obtained from both groups but much more so in dialysis patients (17.5-fold higher). Upregulation of HGFIN and inflammatory cytokines in the uremic monocyte-derived macrophages occurred when grown in the presence of either normal or uremic serum, suggesting the enduring effect of the in vivo uremic milieu on monocyte/macrophage phenotype and function. Conclusions: Uremic macrophages exhibit increased HGFIN gene and protein expression and heightened expression of proinflammatory and a suppressed expression of anti-inflammatory cytokines. Further studies are needed to determine the role of heightened monocyte/macrophage HGFIN expression in the pathogenesis of ESRD-induced inflammation and vascular and soft tissue calcification.Keywords
This publication has 32 references indexed in Scilit:
- IL-18 is involved in vascular injury in end-stage renal disease patientsNephrology Dialysis Transplantation, 2008
- DC-HIL is a negative regulator of T lymphocyte activationBlood, 2007
- Calciotropic Hormones and Arterial PhysiologyJournal of the American Society of Nephrology, 2007
- Expression of osteoactivin in rat and human liver and isolated rat liver cellsJournal of Hepatology, 2005
- Prostaglandin E—A Powerful Anabolic Agent for Generalized or Site-Specific Bone FormationCritical Reviews™ in Eukaryotic Gene Expression, 2003
- Identification and Characterization of the Genes Encoding Human and Mouse OsteoactivinCritical Reviews™ in Eukaryotic Gene Expression, 2003
- Growth Hormone Receptor and Insulin-like Growth Factor-I Immunoreactivity in Osteoclast-like Cells During Tooth Eruption in the Toothless (Osteopetrotic) Rat Following Treatment with Colony-Stimulating Factor-1Critical Reviews™ in Eukaryotic Gene Expression, 2003
- Arterial Calcifications, Arterial Stiffness, and Cardiovascular Risk in End-Stage Renal DiseaseHypertension, 2001
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001
- nmb, a novel gene, is expressed in low‐metastatic human melanoma cell lines and xenograftsInternational Journal of Cancer, 1995